This funding opportunity supports research projects that evaluate the efficacy and clinical effectiveness of multimodality digital health technologies for remotely managing type 2 diabetes. Applicants must conduct clinical trials to assess these interventions, aiming to advance digital health applications in diabetes care.
Eligible applicants include a wide range of U.S.-based organizations such as nonprofits, small businesses, educational institutions, government entities, tribal organizations, and faith-based groups. Foreign organizations and foreign components of U.S. organizations are not eligible.
